# Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants

> **NCT05550129** · PHASE1 · COMPLETED · sponsor: **Amgen** · enrollment: 13 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AMG 510
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05550129
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-13
- **Primary completion:** 2019-11-25
- **Final completion:** 2019-11-25
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05550129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05550129, "Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05550129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*